Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Phreesia (PHR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.35 per share a year ago.
Gear Up for Phreesia (PHR) Q1 Earnings: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.
Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet
The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Phreesia Maintains Its Momentum
Phreesia remains resilient, maintaining guidance and showing strong financial performance, with Q4 revenue growth of 15% year-over-year and improved cash flow. Despite a slight deceleration in customer growth, Phreesia's revenue per healthcare services client increased, driven by network solutions, and the company expects 13.6% revenue growth in fiscal 2026. Future growth drivers include patient education initiatives and Post-Script Engagement, while competition is seen as beneficial, enhancing market awareness and adoption of healthcare solutions.
Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR ) Q4 2025 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Balaji Gandhi - CFO Chaim Indig - Co-Founder, CEO & Director Conference Call Participants Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Jailendra Singh - Triust Securities Ryan Daniels - William Blair Richard Close - Canaccord Genuity Ryan MacDonald - Needham & Company Jeff Garro - Stephens Daniel Grosslight - Citi Group Scott Schoenhaus - KeyBanc Capital Markets Operator Good evening, ladies and gentlemen, and welcome to Phreesia's Fourth Quarter Fiscal 2025 Earnings Conference Call. [Operator Instructions] First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer.
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Phreesia (PHR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.56 per share a year ago.
Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last?
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Phreesia, Inc. (PHR) Soars to 52-Week High, Time to Cash Out?
Phreesia (PHR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Phreesia (PHR) Upgraded to Buy: Here's Why
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Buy Phreesia (PHR) After Golden Cross?
From a technical perspective, Phreesia, Inc. (PHR) is looking like an interesting pick, as it just reached a key level of support. PHR's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High?
The consensus price target hints at a 25% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
